Patents by Inventor Hadi Casser

Hadi Casser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors
    Patent number: 10183036
    Abstract: Compositions are provided including nicotinic acid riboside (“NAR”), and derivatives thereof including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-nicotinic acid (“NAR triacetate” or “NARTA”); or derivatives of a reduced form of nicotinic acid riboside (“NARH”), including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (“NARH triacetate” or “NARH-TA”); or derivatives of nicotinamide riboside (“NR”), including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-nicotinamide (“NR triacetate” or “NRTA”); derivatives of a reduced form of nicotinamide riboside (“NRH”), including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinamide (“NRH triacetate” or “NRH-TA”); or salts or prodrugs thereof, for use in food or beverage applications, pharmaceutical formulations, or as a dietary supplement.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: January 22, 2019
    Assignee: ChromaDex Inc.
    Inventors: Ryan Dellinger, Troy Rhonemus, Mark Morris, Aron Erickson, Hadi Casser, Marie Eugenie Migaud
  • USE OF NICOTINIC ACID RIBOSIDE OR NICOTINAMIDE RIBOSIDE DERIVATIVES, AND REDUCED DERIVATIVES THEREOF, AS NAD+ INCREASING PRECURSORS
    Publication number: 20170304338
    Abstract: Compositions are provided including nicotinic acid riboside (“NAR”), and derivatives thereof including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-nicotinic acid (“NAR triacetate” or “NARTA”); or derivatives of a reduced form of nicotinic acid riboside (“NARH”), including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (“NARH triacetate” or “NARH-TA”); or derivatives of nicotinamide riboside (“NR”), including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-nicotinamide (“NR triacetate” or “NRTA”); derivatives of a reduced form of nicotinamide riboside (“NRH”), including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinamide (“NRH triacetate” or “NRH-TA”); or salts or prodrugs thereof, for use in food or beverage applications, pharmaceutical formulations, or as a dietary supplement.
    Type: Application
    Filed: April 20, 2017
    Publication date: October 26, 2017
    Applicant: Chromadex Inc.
    Inventors: Ryan Dellinger, Troy Rhonemus, Mark Morris, Aron Erickson, Hadi Casser, Marie Eugenie Migaud